Lenalidomide after Stem-Cell Transplantation for Multiple MyelomaPhilip L. McCarthy, Charles Linker, Koen van Besien et al.|New England Journal of Medicine|2012Cited by 1.1k
Triplet Therapy, Transplantation, and Maintenance until Progression in MyelomaPaul G. Richardson, Irene M. Ghobrial, Susanna Jacobus et al.|New England Journal of Medicine|2022Cited by 457
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant ResearchSally Arai, Yoshiko Atsuta, Mukta Arora et al.|Biology of Blood and Marrow Transplantation|2014Cited by 435
Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United StatesLori Muffly, William A. Wood, Marcelo C. Pasquini et al.|Blood|2017Cited by 296
Metabolic Syndrome and Cardiovascular Disease after Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from the CIBMTR and EBMTZachariah DeFilipp, Bronwen E. Shaw, Rafael F. Duarte et al.|Biology of Blood and Marrow Transplantation|2016Cited by 64